We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Krishna Datla, Promoter and MD of Fermenta Biotech announced the appointment of CEO, Prashant Nagre, as the new MD with effect from May 9, 2021. Datla will continue as a Board member and the Executive Vice Chairman.
The initiative will be a part of the Joint Corporate Social Responsibility programme of Fermenta, India’s only manufacturer of Vitamin D3 and a leading player globally along with Indchemie.